Literature DB >> 18196318

Prediction of response to splenectomy in patients with idiopathic thrombocytopenic purpura.

A Shojaiefard1, S A Mousavi, S H Faghihi, S Abdollahzade.   

Abstract

BACKGROUND: Chronic immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by destruction of opsonized platelets in the reticuloendothelial system, particularly the spleen, and by resulting low platelet counts. Splenectomy is the standard second-line treatment for patients with ITP who do not respond to corticosteroids. In the present study we determined predictive factors for the response of patients with ITP to splenectomy.
MATERIALS AND METHODS: For thirty-one patients with ITP referred from the Hematology Department of Shariati Hospital, open surgical splenectomy was performed between February 2002 and December 2004. All potentially important variables of response were collected and analyzed to determine predictive parameters.
RESULTS: Older patients (>52) responded less positively than younger patients (<52) to splenectomy (p<0.01). Likewise, patients with a sustained remission after splenectomy had a significantly shorter interval of diagnosis of ITP to splenectomy (p<0.05) and shorter duration of corticosteroid therapy before splenectomy (p<0.05).
CONCLUSIONS: This study confirms that splenectomy is an effective treatment for patients with ITP. Our findings highlight age as the major predictive factor of long-term response to splenectomy in patients with ITP.

Entities:  

Mesh:

Year:  2008        PMID: 18196318     DOI: 10.1007/s00268-007-9399-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  38 in total

1.  Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura.

Authors:  F Fabris; T Tassan; R Ramon; G Carraro; M L Randi; G Luzzatto; P Moschino; A Girolami
Journal:  Br J Haematol       Date:  2001-03       Impact factor: 6.998

Review 2.  Immune thrombocytopenic purpura.

Authors:  Douglas B Cines; Victor S Blanchette
Journal:  N Engl J Med       Date:  2002-03-28       Impact factor: 91.245

Review 3.  Management of patients with refractory immune thrombocytopenic purpura.

Authors:  J N George
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

Review 4.  Treatment of immune thrombocytopenic purpura in adults.

Authors:  James Bussel
Journal:  Semin Hematol       Date:  2006-07       Impact factor: 3.851

5.  Splenectomy for immune thrombocytopenic purpura: Auckland experience 1979-87.

Authors:  J H Shaw; M A Clark
Journal:  Aust N Z J Surg       Date:  1989-02

6.  Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.

Authors:  Eva Johansson; Per Engervall; Ola Landgren; Gunnar Grimfors; Susanne Widell; Shahideh Rezai; Magnus Björkholm
Journal:  Eur J Haematol       Date:  2006-03-27       Impact factor: 2.997

7.  Clinicopathologic and prognostic features of chronic idiopathic thrombocytopenic purpura in adult Chinese patients: an analysis of 220 cases.

Authors:  A Y Leung; C S Chim; Y L Kwong; A K Lie; W Y Au; R Liang
Journal:  Ann Hematol       Date:  2001-07       Impact factor: 3.673

Review 8.  Pathogenesis and management of chronic idiopathic thrombocytopenic purpura: an update.

Authors:  R Yang; Z C Han
Journal:  Int J Hematol       Date:  2000-01       Impact factor: 2.490

Review 9.  Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.

Authors:  Emmanuel Andrès; Jacques Zimmer; Esther Noel; Georges Kaltenbach; Argyro Koumarianou; Frédéric Maloisel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients.

Authors:  Francisco Javier Peñalver; Victor Jiménez-Yuste; Manuel Almagro; Alberto Alvarez-Larrán; Lluis Rodríguez; Marisol Casado; Laura Gallur; Pilar Giraldo; Roberto Hernández; Dolores Menor; Maria José Rodríguez; Dolores Caballero; Raúl González; José Mayans; Isabel Millán; José Rafael Cabrera
Journal:  Ann Hematol       Date:  2006-03-21       Impact factor: 3.673

View more
  7 in total

Review 1.  Laparoscopic splenectomy for primary immune thrombocytopenia: Current status and challenges.

Authors:  Dong Zheng; Chen-Song Huang; Shao-Bin Huang; Chao-Xu Zheng
Journal:  World J Gastrointest Endosc       Date:  2016-09-16

2.  Predictive factors associated with long-term effects of laparoscopic splenectomy for chronic immune thrombocytopenia.

Authors:  Mingjun Wang; Mengni Zhang; Jin Zhou; Zhong Wu; Ke Zeng; Bing Peng; Ting Niu
Journal:  Int J Hematol       Date:  2013-04-17       Impact factor: 2.490

3.  Late results after splenectomy in adult idiopathic thrombocytopenic purpura.

Authors:  Rosario Vecchio; Eva Intagliata; Francesco La Corte; Salvatore Marchese; Rossella R Cacciola; Emma Cacciola
Journal:  JSLS       Date:  2015 Jan-Mar       Impact factor: 2.172

Review 4.  The Centenary of Immune Thrombocytopenia-Part 2: Revising Diagnostic and Therapeutic Approach.

Authors:  Rita Consolini; Giorgio Costagliola; Davide Spatafora
Journal:  Front Pediatr       Date:  2017-08-21       Impact factor: 3.418

5.  Predictive Factors for Success of Laparoscopic Splenectomy for ITP.

Authors:  Áron Nyilas; Attila Paszt; Bernadett Borda; Zsolt Simonka; Szabolcs Ábrahám; Ágnes Bereczki; Dóra Földeák; György Lázár
Journal:  JSLS       Date:  2018 Oct-Dec       Impact factor: 2.172

6.  Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018.

Authors:  Margareth Castro Ozelo; Marina Pereira Colella; Erich Vinícius de Paula; Ana Clara Kneese Virgilio do Nascimento; Paula Ribeiro Villaça; Wanderley Marques Bernardo
Journal:  Hematol Transfus Cell Ther       Date:  2018-02-17

7.  Immune Thrombocytopenia (ITP) Secondary to Subclinical Hashimoto's Thyroiditis: Role of Levothyroxine in Improving the Clinical Outcome of ITP.

Authors:  Hassan Tahir; Faizan Sheraz; Jahnavi Sagi; Vistasp Daruwalla
Journal:  J Investig Med High Impact Case Rep       Date:  2016-05-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.